Advantage: BPC-157 for rapid, targeted results
In an in vitro model, they used Mller glial cells derived from the retina
That depends on your health goal and medical history
Bentley, P., Calder, I., Elcombe, C., Grasso, P., Stringer, D., and Wiegand, H
Sample 8-Week Starting Protocol | Time | Ipamorelin | GHK-Cu | |------|-----------|--------| | Bedtime (fasted) | 200 mcg SQ | 1 mg SQ | | Morning (optional, fasted) | 200 mcg SQ | Skip or 1 mg topical | | Duration | 8 weeks | 8 weeks | | Washout | 4 weeks | 2 weeks (shorter, no pituitary axis concern) | Dose adjustments should be guided by IGF-1 levels drawn at week 4 (see Monitoring section below)
Grant C